Hypofractionated Stereotactic Irradiation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hypofractionated Stereotactic Irradiation, covering 2022-02-03 to 2022-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344) [NA]